Skip to main content
. Author manuscript; available in PMC: 2016 May 16.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1119–1125. doi: 10.1016/j.ijrobp.2014.08.004

Table 3.

Symptomatic outcomes of neurologic signs or symptoms after radiation therapy (n = 149)*

Resolve Improve Stable Progress




Outcome n (%) n (%) n (%) n (%) Total
CN II 5 (11.9) 22 (52.4) 7 (16.7) 8 (19.0) 42
CN III 1 (6.7) 9 (60.0) 2 (13.3) 3 (20.0) 15
CN IV 1 (33.3) 2 (66.7) 0 (0.0) 0 (0.0) 3
CN V 3 (21.4) 7 (50.0) 3 (21.4) 1 (7.1) 14
CN VI 5 (31.3) 6 (37.5) 2 (12.5) 3 (18.8) 16
CN VII 7 (18.4) 16 (42.1) 5 (13.2) 10 (26.3) 38
CN VIII 0 (0.0) 4 (57.1) 2 (28.6) 1 (14.3) 7
CN IX/X 0 (0.0) 1 (33.3) 1 (33.3) 1 (33.3) 3
CN XII 1 (33.3) 1 (33.3) 0 (0.0) 1 (33.3) 3
Extremity
  weakness
2 (9.1) 15 (68.2) 2 (9.1) 3 (13.6) 22
Extremity
  numbness
0 (0.0) 11 (73.3) 2 (13.3) 2 (13.3) 15
Headache 9 (16.4) 32 (58.2) 8 (14.5) 6 (10.9) 55
Total 34 (14.6) 126 (54.1) 34 (14.6) 39 (16.7) 233

Abbreviation: CN = cranial nerve.

*

Sufficient follow-up information was available for 149 patients with a total of 233 deficits.